These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cardiac involvement in liver cirrhosis. Gatta A; Merkel C; Sacerdoti D; Angeli P Ann Ital Med Int; 1993; 8(4):244-7. PubMed ID: 8161481 [TBL] [Abstract][Full Text] [Related]
4. Circulatory function and hepatorenal syndrome in cirrhosis. Ruiz-del-Arbol L; Monescillo A; Arocena C; Valer P; Ginès P; Moreira V; Milicua JM; Jiménez W; Arroyo V Hepatology; 2005 Aug; 42(2):439-47. PubMed ID: 15977202 [TBL] [Abstract][Full Text] [Related]
5. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention? Møller S; Henriksen JH Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398 [TBL] [Abstract][Full Text] [Related]
6. [Systemic circulatory hyperkinetic syndrome in patients with cirrhosis. Relation with hepatocellular failure and portal hypertension]. Valla D; Poynard T; Bercoff E; Bataille C; Goldfarb G; Lebrec D Gastroenterol Clin Biol; 1984 Apr; 8(4):321-4. PubMed ID: 6735039 [TBL] [Abstract][Full Text] [Related]
7. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis. Gentilini P; Laffi G; La Villa G; Raggi VC Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019 [TBL] [Abstract][Full Text] [Related]
11. Ascites in liver diseases. Gentilini P; Laffi G Ann Ital Med Int; 1991; 6(1 Pt 2):148-55. PubMed ID: 1742150 [TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of ascites in cirrhosis and portal hypertension. Heneghan MA; Harrison PM Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415 [TBL] [Abstract][Full Text] [Related]
14. Hemodynamic alterations in liver cirrhosis. La Villa G; Gentilini P Mol Aspects Med; 2008; 29(1-2):112-8. PubMed ID: 18177931 [TBL] [Abstract][Full Text] [Related]
15. [Renal and extra-renal mechanisms of sodium and water retention in cirrhosis with ascites]. Peña JC Rev Invest Clin; 1995; 47(1):63-79. PubMed ID: 7777718 [TBL] [Abstract][Full Text] [Related]
16. [Natural course and physiopathology of ascites in the cirrhotic patient]. Bernardi M; Colantoni A; Caraceni P; Sica G; Trevisani F Ann Ital Med Int; 1996 Oct; 11 Suppl 2():30S-38S. PubMed ID: 9004818 [TBL] [Abstract][Full Text] [Related]
17. Fluid retention in cirrhosis: pathophysiology and management. Kashani A; Landaverde C; Medici V; Rossaro L QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668 [TBL] [Abstract][Full Text] [Related]
18. [The pathophysiology of ascites formation in cirrhosis of the liver]. Benjaminov FS Harefuah; 2002 Aug; 141(8):721-5, 760. PubMed ID: 12222138 [TBL] [Abstract][Full Text] [Related]
19. [Hepatorenal syndrome: pathogenesis and treatment]. Ashkenazi E; Ilan Y; Shoval D Harefuah; 2007 Jun; 146(6):475-9, 499. PubMed ID: 17760404 [TBL] [Abstract][Full Text] [Related]
20. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046. Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]